Potential of Human Embryonic Stem Cells in Cartilage Tissue Engineering and Regenerative Medicine

Toh, Wei; Lee, Eng; Cao, Tong
September 2011
Stem Cell Reviews & Reports;Sep2011, Vol. 7 Issue 3, p544
Academic Journal
The current surgical intervention of using autologous chondrocyte implantation (ACI) for cartilage repair is associated with several problems such as donor site morbidity, de-differentiation upon expansion and fibrocartilage repair following transplantation. This has led to exploration of the use of stem cells as a model for chondrogenic differentiation as well as a potential source of chondrogenic cells for cartilage tissue engineering and repair. Embryonic stem cells (ESCs) are advantageous, due to their unlimited self-renewal and pluripotency, thus representing an immortal cell source that could potentially provide an unlimited supply of chondrogenic cells for both cell and tissue-based therapies and replacements. This review aims to present an overview of emerging trends of using ESCs in cartilage tissue engineering and regenerative medicine. In particular, we will be focusing on ESCs as a promising cell source for cartilage regeneration, the various strategies and approaches employed in chondrogenic differentiation and tissue engineering, the associated outcomes from animal studies, and the challenges that need to be overcome before clinical application is possible.


Related Articles

  • Strategies for enrichment and selection of stem cell-derived tissue precursors. Bernstein, Harold S.; Hyun, William C. // Stem Cell Research & Therapy;2012, Vol. 3 Issue 3, p1 

    Human embryonic stem cells have the capacity for self-renewal and pluripotency and thus are a primary candidate for tissue engineering and regenerative therapies. These cells also provide an opportunity to study the development of human tissues ex vivo. To date, numerous human embryonic stem...

  • Human stem cell research and regenerative medicine—present and future. Volarevic, Vladislav; Ljujic, Biljana; Stojkovic, Petra; Lukic, Aleksandra; Arsenijevic, Nebojsa; Stojkovic, Miodrag // British Medical Bulletin;Sep2011, Vol. 99 Issue 1, p155 

    Introduction Stem cells are cells with the ability to grow and differentiate into more than 200 cell types. Sources of data We review here the characteristics and potential of human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs). Areas of...

  • Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation. Lázaro, I.; Kostarelos, K. // Stem Cell Reviews & Reports;Feb2016, Vol. 12 Issue 1, p129 

    Changes in cell identity occur in adult mammalian organisms but are rare and often linked to disease. Research in the last few decades has thrown light on how to manipulate cell fate, but the conversion of a particular cell type into another within a living organism (also termed in vivo...

  • Regulatory Influence of Scaffolds on Cell Behavior: How Cells Decode Biomaterials. Pennesi, G.; Scaglione, S.; Giannoni, P.; Quarto, R. // Current Pharmaceutical Biotechnology;Feb2011, Vol. 12 Issue 2, p151 

    No abstract available.

  • Biology of Mesenchymal Stem Cells. Jakob, Franz; Limbert, Catarina; Schilling, Tatjana; Benisch, Peggy; Seefried, Lothar; Eber, Regina // Current Rheumatology Reviews;2008, Vol. 4 Issue 3, p148 

    Mesenchymal stem cells (MSC) are derived from mesodermal precursor and are committed towards mesenchymal differentiation. They are scattered all over the organism, situated in bone, cartilage, adipose tissue and accompany organs for tissue regeneration and structural and functional support. MSC...

  • Chromatin structure of pluripotent stem cells and induced pluripotent stem cells. Delgado-Olguín, Paul; Recillas-Targa, Félix // Briefings in Functional Genomics;Jan2011, Vol. 10 Issue 1, p37 

    Pluripotent embryonic stem (ES) cells are specialized cells with a dynamic chromatin structure, which is intimately connected with their pluripotency and physiology. In recent years somatic cells have been reprogrammed to a pluripotent state through over-expression of a defined set of...

  • Selective Removal of Undifferentiated Embryonic Stem Cells from Differentiation Cultures Through HSV1 Thymidine Kinase and Ganciclovir Treatment. Naujok, Ortwin; Kaldrack, Joanna; Taivankhuu, Terbish; Jörns, Anne; Lenzen, Sigurd // Stem Cell Reviews & Reports;Sep2010, Vol. 6 Issue 3, p450 

    Pluripotent cell lines such as embryonic stem cells are an attractive source for a potential cell replacement therapy. However, transplantation of differentiated cells harbors the risk of teratoma formation, presenting a serious health risk. To overcome this obstacle, a negative selection system...

  • Spatial Pattern Dynamics of 3D Stem Cell Loss of Pluripotency via Rules-Based Computational Modeling. White, Douglas E.; Kinney, Melissa A.; McDevitt, Todd C.; Kemp, Melissa L. // PLoS Computational Biology;Mar2013, Vol. 9 Issue 3, p1 

    Pluripotent embryonic stem cells (ESCs) have the unique ability to differentiate into cells from all germ lineages, making them a potentially robust cell source for regenerative medicine therapies, but difficulties in predicting and controlling ESC differentiation currently limit the development...

  • Loss of discordant cells during micro-mass differentiation of embryonic stem cells into the chondrocyte lineage. Yamashita, A.; Krawetz, R.; Rancourt, D. E. // Cell Death & Differentiation;Feb2009, Vol. 16 Issue 2, p278 

    Embryonic stem cells (ESCs) have attracted particular interest in regenerative medicine because of their unlimited self-renewal and multipotentiality for differentiation. Spontaneous differentiated ESCs display heterogeneous multipotent cell populations and generate teratomas in vivo, with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics